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SUMMARY
A cellophane square technique has been used to determine Minimum 
Inhibitory Concentrations and morphological changes induced by exposure 
of various medically important fungi to antifungal agents. The procedure 
allows earlie r assessm ent of fungistatic and fungicidal activity than can be 
achieved by conventional techniques.
Fungistatic activity of the imidazoles has been shown not to be affected 
by the phase of growth of the fungi, but fungicidal activity of miconazole and 
econazole was found to be more pronounced against the actively growing 
phases of both yeasts and filamentous fungi. Ketoconazole differed by 
having significantly higher M. I. C. levels against the test fungi, but was 
m ore effective in killing stationary phase cells of Trichophyton mentagrophytes. 
However, fungicidal activity of ketoconazole against both actively growing 
and stationary phase cells of Candida albicans was low compared to the other 
two imidazoles.
A feature which was peculiar to the yeasts C. guilliermondii and 
C. tropicalis was observed on sub-fungi static concentrations of miconazole, 
econazole and ketoconazole. These yeasts were particularly sensitive to 
low concentrations of the imidazoles, but at higher concentrations there was 
some relief of toxicity resulting in partial recovery before growth was 
finally inhibited by fungistatic concentrations. Since these two yeasts also 
differed from others in their response to thiamin, the presence of trace
X
amounts of this vitamin in the medium may account for the phenomenon. 
Alternatively the imidazoles may affect a number of different metabolic 
pathways within the fungal cell.
Resistance to the antifungal agents did not arise  spontaneously in any 
of the fungi during the course of this study. However, physiological 
adaptation which resulted in an approximate two-fold increase in the amount 
of growth of C. guilliermondii on econazole was observed although M. I. C. 
levels remained unaltered, and increased resistance to the imidazoles was 
induced in Aspergillus nidulans with U. V. light as the mutagenic agent.
The potential for resistance to the imidazoles to arise  spontaneously in these 
fungi therefore exists.
Selected antifungals were also examined for their in vivo activity.
When administered orally, ketoconazole was found to be highly effective in 
curing ringworm infections in guinea pigs. Topical application of miconazole 
was shown to be as effective as an established treatm ent for ringworm, 
(tolnaftate), against experimentally induced dermatophytosis in guinea pigs.
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G E N E R A L  IN T R O D U C T I O N
Fungi were f irs t recognised as pathogens in the 19th Century when 
Agostino Bassi demonstrated that muscardine disease of silkworms was 
caused by the fungus now known as Beauveria bassiana. During the next 
ten years the fungi associated with favus and thrush in man were described. 
However, it was left inconclusive whether such fungi were the result or the 
cause of disease. The work of Pasteur and Koch clearly defined the role of 
bacteria in disease and, la ter, protozoa and viruses were also recognised 
as pathogens, but fungi were virtually ignored.
A preliminary survey (Duncan, 1945) showed mycotic infections to be 
common in Britain, and more than sixty species of fungi were claimed as 
pathogenic for man and animals (Ainsworth, 1950),
Effective prophylactic and control m easures reduce the number of 
deaths due to bacterial and viral infections. No control m easures are 
known for several of the mycoses which may be fatal, and although a number 
of the most widespread mycotic infections are seldom fatal, they may cause 
considerable d istress to the patient and are often difficult to cure.
Within the past few decades it has been realised that the division 
between pathogenic and non-pathogenic fungi is not clearly defined. 
Opportunistic fungal infections occur when predisposing factors that lead to 
lowered host resistance allow normally harm less commensal or saprophytic 
organisms to become pathogenic (e. g. Candida spp. and Aspergillus spp. ). 
Such infections have become an increasing problem in recent years with the 
growing use of immunosuppressive therapy, valve replacement surgery and 
the increased survival of patients with congenital and acquired 
immunodefici enci es.
Chemotherapy of the systemic mycoses is restric ted  to only a few 
agents, and topical treatm ent of superficial infections is of limited success 
because of the problem of penetration of the agents to the site of fungal 
activity. As a result treatm ent failures in all forms of mycoses are not 
uncommon and a search is continuing for new, effective, non-toxic agents.
The requirements for successful chemotherapy are  that the target site 
on the pathogen must be essential for growth, and the host must be resistant 
to the effects of the drug.
In the case of bacterial pathogens there are vast differences in the 
physiology of the prokaryotic organism and the eukaryotic host, and 
consequently there are  numerous targets for drug action. Fungi, however, 
are eukaryotic organisms and the differences between them and their hosts 
are much fewer.
Major differences exist between the cell envelopes of animals and fungi. 
A cell wall is absent in animals while in fungi it is a complex structure 
containing polysaccharides, protein and lipids. The membrane sterol in 
animals is cholesterol while in fungi it is ergosterol. It is , therefore, to be 
expected that the cell envelope would provide the ideal target site for 
antifungals.
The firs t antifungal antibiotic to be isolated and found suitable for 
therapeutic use was nystatin in 1949 (Hazen & Brown, 1950). It contains a 
number of conjugated carbon-carbon double bonds in a polyhydroxylic 
lactone ring and was designated a "polyene". Nystatin is used prim arily in 
the treatm ent of non-systemic Candida infections and is administered orally 
or topically. Oral administration, as used in the treatm ent of intestinal 
candidosis, does not lead to significant serum levels of the drug since
absorption of nystatin from the gastro-intestinal trac t of man is slight.
Numerous other polyene antibiotics have been described, but only a 
few have received much attention as useful antifungal agents because of the 
high degree of toxicity inherent in all of them. Only one, Amphotericin B, 
has led to a significant advance in the treatm ent of systemic fungal infections 
(Utz & Andriole, 1960).
Work by Gold et al. , (1956); Gottlieb et a l . ,  (1958) and Gale , (1963) 
and summarised by Lam pen, (1966) has shown that polyenes interact with 
membranes of sensitive organisms causing leakage of internal constituents 
and ultimately cell death. The nature of the components lost depends on the 
nature of the polyene; the sm aller the polyene molecule, the greater the 
membrane damage.
Another antifungal antibiotic, griseofulvin, firs t isolated by Oxford 
et al. , in 1939, and again independently by Brian et al. , (1946), was found to 
be useful in the treatm ent of animal ringworm infections when administered 
orally (Gentles, 1958). The compound causes the mycelium of susceptible 
fungi to become stunted and in lower concentrations stimulates the 
development of regular helical curling of the hyphae. Gull & Trinci,
(1973; 1974), suggest that griseofulvin inhibits m itosis in fungi by binding 
to microtubule-associated proteins, although other workers dispute this 
theory (Grisham et al. , 1973).
Attention has recently been focussed on synthetic antifungal compounds, 
Tolnaftate was selected from some 3,000 naphthiomates, synthesised 
during a ten year search for new fungicidal agents (Noguchi et al . , 1962).
The compound has high activity against dermatophytes and certain other 
mycelial fungi, but has no effect upon the growth of C. albicans.
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FIGURE 1 Structural formulae of some antifungals
5-Fluorocytosine has been introduced as a treatm ent for certain systemic 
fungal infections. It has the advantage of being relatively non-toxic. However 
problems are encountered because of the development of resistan t strains.
(Such problems have not occurred with the polyenes or griseofulvin) This 
fluoro-pyrimidine is thought to act by interfering with RNA synthesis 
(Giege & Weil, 1970).
Imidazole derivatives have been used in the treatm ent of protozoal and 
helminth infections for almost 30 years (Holt, 1976), Jh 1969 two quite 
distinct imidazoles with marked antifungal activity entered laboratory and 
clinical trials; these were clotrimazole and miconazole. Two more are now 
on the market; chlormidazole and econazole, and a third, ketoconazole, is 
currently undergoing intensive investigation (see Fig. 2 for structural 
formulae).
IMIDAZOLES WITH ANTIFUNGAL ACTIVITY
Buchel et a l . , (1972) made a deliberate search during the last decade 
for imidazoles with antifungal activity. They concentrated on tritylimidazole 
derivatives, substituted in either one, two or all three benzene rings and found 
that many of these compounds had considerable antifungal activity both in vitro 
and in vivo. A tritylimidazole with chlorine substituted in one benzene ring 
was eventually selected for further study and given the name clotrimazole.
Godefroi et a l . , (1969) studied the antifungal properties of derivatives 
of 1 - phenethyl imidazole. One of these compounds, miconazole nitrate, 
was reported by Van Cutsem & Thienpont (1972) to be active against the 
dermatophytes, yeasts, dimorphic fungi, aspergilli and the mycetoma - 
causing agents as well as against gram-positive bacteria.
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FIGURE 2 Structural formulae of imidazoles
Econazole is another 1 -  phenethyl derivative, differing from miconazole 
only in containing one less chlorine atom. The spectrum of activity of 
miconazole and econazole is sim ilar, although there are  differences in the 
sensitivity of some of the fungi (Schar et a l , , 1976),
Clotrimazole, miconazole and econazole have all been used systemically 
with varying success against deep mycoses, but all suffer from certain defects 
and their most important use at present is  as topical preparations for the 
treatm ent of dermatophyte and superficial yeast infections (Holt, 1976),
The chlorbenzyl imidazole, chlormidazole, is  available solely as a 
cream, tincture o r powder for topical use. Its properties are  described by 
Seeliger, (1958) and reviewed by Holt in 1976, It shows no advantages over 
the other imidazoles and although frequently used in certain European 
countries, it is  not in general use in the U.K,
A new imidazole derivative,ketoconazole, is  active when administered 
orally in the treatm ent of experimental dermatophytosis in guinea pigs and 
experimental systemic candidosis in rabbits (Odds et a l . , 1980), It is 
also active in vitro against several fungi causing deep mycoses, specifically 
Coccidioides im m itis, Blastomyces derm atitidis, Histoplasma capsulatum 
and Crvptococcus neoform ans (Dixon et al. , 1978) and when administered 
orally is  active against C, immitis infections in mice (Levine & Cobb, 1978). 
MECHANISM OF ACTION OF THE IMIDAZOLES
The mechanism of the antifungal activity of the imidazoles has not yet 
been fully elucidated.
Using C. albicans as the test organism Iwata et a l. , (1973a) suggested 
that fungicidal concentrations of clotrimazole damaged the permeability 
b arrie r, possibly through reaction with the cell membrane. Leakage of
intracellular phosphorus compounds and potassium ions then led to 
inhibition of macromolecular synthesis.
Electron microscopic studies by the same workers, (Iwata et a l . ,
1973b), revealed that exposure to fungicidal levels of clotrimazole induced 
unusual development and eventual destruction of certain membranous 
structures. The yeast cell membrane was seen to invaginate to form 
extensive intracytoplasmic membranes in the vicinity of vacuoles, and the 
nuclear and mitochondrial inner membranes appeared to deteriorate. The 
term inal event appeared to be complete loss of the nuclear membrane 
(Yamaguchi et a l . , 1973).
Similar studies with clotrimazole were made by Puccinelli et a l . , (1977) 
on the mycelial fungus Mlcrosporum canis. Deterioration of the plasma 
membrane was again noted, but these workers were unable to decide whether 
it was induced directly by the clotrimazole or if it was a consequence of 
generalized cell damage.
Electron microscopic examination of C. albicans cells after exposure to 
different concentrations of miconazole also revealed degradation of the intracyto­
plasmic membrane systems (De Nollin & Borgers, 1974). This effect is also 
reported in C. albicans and in Trichophyton rubrum after treatm ent with 
econazole (P reusser, 1976 and P reusser & Zimmerman, 1975).
These changes are  now thought to be the morphological translation 
of the biochemical effects of the imidazoles on phospholipids and on 
ergosterol biosynthesis, recently described by Yamaguchi, (1978) and 
Van den Bossche et a l . , (1978).
Using a new method of preparation to overcome the problem of inadequate 
penetration of fixatives into yeast cells, De Nollin et a l . , (1975, 1977) studied
cytochemical changes in the topographic distribution of a number of enzymes 
in cells exposed to fungistatic and fungicidal levels of miconazole. Decreased 
cytochrome oxidase and peroxidase activity was demonstrated and it was 
postulated that the differences in sensitivity of actively growing and 
stationary phase cells to the fungicidal effect of the imidazoles may be due to 
differences in the level of these enzymes in the cells before they are exposed 
to the drug. Actively growing cells which do not have an adequate supply of 
cytochrome oxidase and peroxidase are unable to synthesise the enzymes in the 
presence of the drug and are, therefore, unable to break down hydrogen 
peroxide. The cells therefore die.
Dickinson (1977) examined the effects of miconazole on isolated rat 
liver mitochondria and found that it caused an uncoupling and at higher 
concentrations an inhibition of oxidative phosphorylation.
Another biochemical study by Van den Bossche (1974) showed that 
miconazole inhibited the transport of adenine, guanine and hypoxanthine into 
C. albicans cells but did not inhibit transport of glucose, glycine or leucine.
He also showed by studies on the distribution of labelled miconazole in the 
Candida cell that in log-phase cells most of the radioactivity becomes localized 
in the fraction containing cell walls and plasmalemma and that in stationary- 
phase cells the highest radioactivity is present in the microsome fraction. 
These differences in distribution of the drug may reflect the differences in 
sensitivity of actively growing and stationary phase cells to the fungicidal 
activity of the imidazoles.
The ability of miconazole to cause leakage of potassium and sodium 
ions was demonstrated by Swamy et a l . , (1974) in yeast cells, and also, 
unexpectedly, in sheep erythrocytes (Swamy et a l . , 1976 a). These
workers also found a lysosome-labilizing action of the drug (1976b).
Other properties of the imidazoles also have a bearing on their 
activity both in vitro and in vivo.
The antifungal activity of both miconazole and clotrimazole is blocked 
from full expression in complex media but not in synthetic media (Hoeprich 
& Finn, 1972). Hoeprich & Huston (1976) suggested that possibly the lipids 
in the undefined media could cause antagonism through sequestration, and 
the findings of Yamaguchi (1977, 1978) and Kuroda et a l . , (1978) support this 
view. Binding of the drugs to lipids, or to plasma proteins as demonstrated 
by Chappel (1975), would be expected to interfere with their in vivo activity.
Certain other imidazole derivatives, in particular Tetram isole and 
Levamisole, possess immuno-modulating properties. It is uncertain if 
the antifungal imidazoles affect the immune response of the host but it has 
been suggested by Harkness & Renz (1974) that clotrimazole-induced 
stimulation of host resistance factors, such as leukocyte myeloperoxidase, 
may play a role in drug action in vivo. Conversely, Thong & Rowan-Kelly 
(1978) report that miconazole had an inhibitory effect on mitogen-induced 
lymphocyte proliferative responses, and since recovery from severe mycotic 
infections may need at least minimal immune responses, this immuno­
suppressive property of miconazole may be undesirable.
Despite the lack of understanding of the exact mode of action of the 
imidazole group of antifungals, these drugs are being used to trea t a wide 
range of fungal infections in man and animals.
OBJECT OF RESEARCH
There is a need for more effective agents for treatm ent of human and 
animal mycotic infections. Of the drugs available, many are suitable only 
for topical application, and those administered systemically all have certain 
limitations, for example, narrow spectrum of activity, high degree of 
toxicity, or the occurrence of natural or induced resistance. Recently, 
imidazole compounds have been, and are still being, intensively investigated 
with a view to filling this need for a broad spectrum drug which can be easily 
and safely administered.
Reports of in vitro activity of those drugs introduced for clinical use 
show a wide variation in results because of different investigational conditions. 
The composition of the medium, the duration of incubation, the phase of 
growth, the size of the inoculum and the test fungi have all clearly influenced 
the results obtained by various workers.
The firs t object of this study was to establish a procedure for comparing 
the fungistatic and fungicidal activity of certain imidazoles against different 
growth phases and different morphological forms of medically important 
fungi and to compare their in vitro activity with that of other antifungals.
Although the development of resistance to the imidazoles has not been 
a significant problem in therapy of mycotic infection, a second object of 
this research was to study the possible development of resistance to the 
imidazoles in vitro.
Thirdly, since in vitro activity, although important, may give little 
indication of the clinical efficacy of a drug, tests were made on guinea pigs 
experimentally infected with ringworm to ascertain the potential of certain
of the imidazoles in the treatm ent of dermatophytosis.
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EXPERIMENTAL SECTION 1
IN VITRO ACTIVITY OF ANTIFUNGALS
I N T R O D U C T IO N
In vitro sensitivity testing is routinely employed to determine the 
activity of a drug against the etiologic agent of a disease. It is desirable 
that such tests should be standardised in order to obtain consistent results 
within and between laboratories.
The techniques employed for testing the imidazoles clearly need to be 
critically assessed as considerable variations in Minimum Inhibitory 
Concentrations (M. I. C. ) are  to be found in the literature. For example, the 
following M. I. C. levels of miconazole have been quoted by different workers 
for C. albicans isolates: 0. 5jug/ml (Holt, 1972), 2jLtg/ml (Milne, 1978),
16/Ltg/ml (Shadomy et al. , 1977) and recently Holbrook & Kippax (1979) reported 
sensitivities ranging from 8 to 32jng/ml.
Certain authors have considered that the growth medium is mainly 
responsible for the variation in results.
Plempel & Buchel (1975), stated that peptone interfered with the 
activity of the imidazoles and Hoeprich & Huston, (1976) advocated the use of 
defined media for testing the in vitro activity of miconazole. Conversely, 
Swamy et a l . . (1974) reported that growth inhibition by miconazole was less
'f""!” I'-l"in synthetic media, where divalent cations, notably Mg and Ca were 
present, than in glucose peptone medium.
Antagonism to clotrimazole and miconazole has been observed with 
phospholipids containing an unsaturated acyl group and also with 
acylglycerides, the ester portion of which consists of unsaturated fatty 
acids (Yamaguchi, 1977; 1978 and Kuroda et al. . 1978). In addition 
polyoxyethylene surfactants were found to antagonise the anti-Candida 
activity of clotrimazole (Iwata & Yam aguchi, 1977).
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However, the contents of the medium are not the only factor that 
influences the results of M. I. C. tests. It is generally accepted that M. I. C. 
levels vary according to the size of the inoculum, and recently Langsadl & 
Jedlikova (1979) have produced quantitative evidence of this with the imidazoles. 
They demonstrate that the M. I. C. of miconazole against 12 laboratory strains 
of C. albicans varied between 0. 39 and 12. 5jug/ml for an inoculum size of
g
2 X 10 CFU/ml, and between 0. 025 and 1. 56jug/ml for an inoculum size of 
41, 6 X 10 CFU/ml. Inoculum size is also recognised to be important when 
attempting to measure fungicidal activity of the imidazoles (Yamaguchi 
& Iwata, 1979).
The duration of incubation needs to be considered and must be varied 
according to the rate of growth of the test fungus. In the tube dilution test, 
results for the fast-growing yeasts can be determined after 48 hours, 
whereas the slower-growing dermatophytes require 7 - 1 0  days incubation.
It should be appreciated also that the end-point is not always sharply 
defined. For example, a marked drop in the amount of growth relative to 
controls may be observed with C. albicans on minimum inhibitory 
concentrations of the imidazoles, but some multiplication of the inoculum takes 
place even above this although it becomes progressively less obvious as the 
concentration of drug increases. A modification of the definition of M. I. C. 
is therefore required when interpreting results of tests with imidazole antifungals.
The evidence to date concerning the possibility of resistance arising 
during the course of treatm ent with imidazoles indicates that it is not 
likely to be a problem. There is only one report of Candida developing 
resistance to miconazole following 6 months therapy (Holt & Azmi, 1978).
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Investigations of the imidazoles with the gradient plate method 
(Szybalski & Bryson, 1952), have failed to demonstrate the development of 
resistance (Schweisfurth, 1974 and Holt, 1976). However, some attention was 
given in this study to the possibility of resistance arising spontaneously or 
following treatm ent with a mutagenic agent.
12
PRELIMINARY INVESTIGATIONS
Before embarking upon a detailed study of the fungicidal and fungistatic 
activity of the imidazoles it was f irs t necessary to find a procedure which 
would give consistent results and which could be used for all drugs and 
all fungi under test.
Prelim inary tests showed glucose peptone medium to be satisfactory for 
assessing the antifungal activity of all the agents under examination and 
recent publications, (Borgers et a l . , 1977; Shadomy et a l . , 1977; Odds et al. , 
1980 ) have also indicated that it is  widely accepted as a suitable medium 
for testing imidazoles. Since this medium readily supports the growth of 
both yeasts and filamentous fungi it was ideally suited for the purposes of 
this study.
Using broth and agar dilution tests and inocula of standard size, it was 
found that consistent results could be obtained for fungistatic activity of 
various imidazoles, however certain initial problems were encountered in 
attempts to determine fungicidal activity.
(1) When transferring fungi which had been exposed to fungicidal concentrations 
of the imidazoles to drug-free medium to test for viability, it became apparent 
that fungistatic concentrations of the drugs were being carried  over and this 
interfered with determination of viability. This was clearly a factor which 
was not taken into consideration by other workers (Janssen Pharmaceutica, 
1971) in their attempt to determine fungicidal activity of miconazole against 
filamentous fungi contained in agar blocks. Since miconazole is  a charged 
molecule the possibility was examined that it was binding to the agar by 
electrostatic forces, however since non-ionic agarose also retained 
fungistatic concentrations of the drug this technique had to be abandoned.
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The insoluble imidazoles could not be removed by centrifugation and 
washing procedures, and transfer of fungi on cellophane squares from drug- 
containing to drug-free media served only to illustrate  the efficiency with 
which cellophane absorbs the imidazoles I
Eventually a method was found which overcame this problem of carry ­
over -  that of providing an inoculum containing sufficient viable units to 
allow dilution to reduce the drug concentration to below fungistatic levels 
before testing for viability.
(2) The intravenous preparation of miconazole has the advantage of remaining 
in m icro -su sponsion when diluted in distilled water, and for this reason it 
was used in early studies. It was found to be quite satisfactory for the 
determination of M. I. C. s, but fungicidal activity could not be demonstrated.
When dimethyl form amide was used as solvent fungicidal activity was 
achieved and it seemed, therefore, possible that the solubilising agent present 
in the i.v . preparation, Cremophor E L (polyethoxylated castor oil), was 
antagonising the activity of miconazole. This was confirmed by addition of 
appropriate dilutions of Cremophor E L to tubes of glucose peptone broth 
containing miconazole dissolved in dimethyl formamide and the finding is 
substantiated by the reports of antagonism by unsaturated fatty acids and 
polyoxyethylene surfactants (Yamaguchi, 1977, 1978, Kuroda et a l . , 1978 and 
Iwata & Yamaguchi, 1977).
Consequently, dimethyl formamide was used as solvent for the non­
water-soluble imidazoles throughout the study of in vitro activity reported here.
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M A T E R I A L S  A N D  M E T H O D S
MATERIALS
TEST ORGANISMS
The following fungi were either isolated or received as cultures from 
clinical m aterial and identified in this laboratory.
Yeasts:
Candida albicans (BP 3496 B)
C. parapsilosis (BP 3418)
C. tropicalis (BP 3437)
C. guilliermondii (BP 3439)
C. pseudotropicalis (BP 3344)
Filamentous fungi:
Aspergillus fumigatus (BP 3524)
MLcrosporum canis (MC 6) *
Trichophyton mentagrophytes 
var. interdigitale (DO 9941C) *
T. rubrum (SD 801)
Source
faeces
skin
faeces
faeces
faeces
Date
13.11.78 
1. 9. 78
18.9.78
20.9.78
19.7.78
sputum
scalp
toe nail 
toe nail
30.11.78
30. 4. 75
30.9.77 
25.7. 78
* Filamentous fungi, especially dermatophytes, deteriorate if sub­
cultured repeatedly over a prolonged time. For this reason T. mentagrophytes 
var. interdigitale (DO 9941C) and M. canis (MC 6) were stored on silica gel 
(Gentles & Scott, 1979) soon after isolation. The studies with 
T. mentagrophytes var. interdigitale extended over many months. Sub-cultures 
of this fungus were made every two weeks on glucose peptone agar for a 
maximum of 3 months before being replaced from the silica gel stock.
M. canis was freshly cultured from silica gel shortly before use and sub-
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culturing was kept to a minimum during the few weeks taken to perform the 
experiments described.
The Aspergillus nidulans mutants used in the investigations undertaken 
jointly with Mr. E. Forbes are available in the Genetics Department, 
Glasgow University.
Mutant Glasgow Number
an B8 026
b i - 1  
pro A 1 
pyro -  4 
ribo A 1
051
0157
0177
0189
MEDIA
Glucose " peptone medium
Composition/litre
Glucose 40 g
Peptone (for Bacteriological
work) (Fisons) 10 g
Agar (for solid medium) 20 g
Sterilised by autoclaving at 121°C for 20 min.
Czapek-Dox + Tween 80 agar
C ompositi on/litre
Czapek-Dox Agar (Qxoid) 45.4 g
Tween 80 10 ml
Sterilised by autoclaving at 115°C for 20 min.
16
The formulae for the Czapek-Dox medium and minimal medium, and
the methods of preparation of the supplements used in the experiments
performed in collaboration with Mr. E. Forbes are described by Cove, (1966)
modified after Pontecorvo et a l . , (1953):-
Czapek-Dox medium
C ompo siti on/litre
Sodium nitrate 6 g
Potassium chloride 0. 52 g
Magnesium sulphate 0. 52 g
Potassium dihydrogen
orthophosphate 1.02 g
Trace elements 1 ml
Trace elements
C ompo siti on /litre
Sodium tetraborate 0. 04 g
Copper o r cupric sulphate 0.4 g
F erric  orthophosphate 0. 8 g
Manganese sulphate 0. 8 g
Sodium molybdate 0. 8 g
Zinc sulphate 0. 8 g
Minimal medium
C ompo siti on/litre
Czapek-Dox medium 11
Glucose 10 g
Agar 12 g
pH adjusted to 6. 5
Sterilized by autoclaving at 121°C for 15 min.
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Ammonium was supplied as ammonium tartra te  (10 m mol). 
Vitamins were added at a concentration of 0. 05^g/ml.
CELLOPHANE SQUARES
Cellophane squares for use in the study of morphological changes 
were prepared as follows
One cm. squares of non-moisture-proof cellophane (’’Crystal" jam 
pot covers) were sterilised by autoclaving between moist filte r paper at 
121°C for 20 min.
DRUGS
Antifungal drugs were obtained as follows :-
MICONAZOLE and KETOCONAZOLE from Janssen Pharmaceutical 
Limited, Janssen House, Marlow, Bucks.
ECONAZOLE from Cilag- Chemie Limited,
CH-8201, Schaffhausen, Switzerland
CLOTRIMAZOLE from Bayer Pharmaceuticals Limited, Haywards 
Heath, Sussex.
TOLNAFTATE and GRISE OFULVIN from Glaxo Laboratories Limited, 
Greenford, Middlesex.
The solubilising agent, Cremophor E L, (polyethoxylated castor oil), 
used in the preparation of i.v . miconazole, was provided by Janssen 
Pharmaceutical Limited.
Stock solutions containing 10 mg/m l were prepared in the appropriate 
solvent, (dimethyl formamide for miconazole, econazole and clotrimazole; 
sterile distilled water for ketoconazole; acetone for tolnaftate and griseofulvin), 
further dilutions were made in sterile distilled water immediately before use.
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The intravenous preparation of miconazole, supplied by Janssen 
Pharmaceutical Limited, contained 10 mg/ml maintained in micro-suspension 
by 0.1 ml of Cremophor E L/m l and with various other additions, details of 
which were not revealed by the manufacturer. It was used in early 
experiments but found not to be satisfactory for m easurements of fungicidal 
activity.
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METHODS
PREPARATION OF ACTIVE AND STATIONARY GROWTH PHASES
(i) Yeasts
The actively growing phase of Candida species was obtained by 
inoculating 0,1 ml of a suspension containing approximately 10  ^ cells/m l 
into glucose peptone broth and incubating for 18 h at 28°C. A dilution of
1 ; 100 of this culture in fresh broth was then incubated at 28^C for a further
2 h period. This procedure gave counts in the region of 10  ^ cells/m l.
Stationary phase cells were obtained from a 10 day old culture on 
glucose peptone agar, and suspensions of approximately equal turbidity to 
the actively growing cell cultures were prepared in glucose peptone broth. 
Morphological study Volumes of 0. 01 ml of the suspensions were placed on 
the surface of agar medium containing the drugs and left to stand for 10 - 15 
min to allow the liquid to be absorbed into the agar before covering the 
areas with cellophane squares.
Fungicidal study Cell suspensions were dispensed in 4. 5 ml amounts in 
sterile  tes t tubes immediately before addition of drug.
(ii) Filamentous fungi
Morphological study Actively growing hyphal cells were prepared using a 
modification of a technique employing cellophane squares, (Carmichael, 1956; 
Chabbert, 1957; Kondo et a l . , 1959).
Cellophane squares were placed on drug-free glucose peptone agar and 
left for approximately 10 min to absorb m oisture and adhere firmly to the 
surface of the medium.
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5An inoculum of 0, 01 ml of a suspension containing approximately 10 
freshly harvested spores, (from 10 day old cultures), per ml of distilled water 
was placed on each square and the dishes incubated at 28^C for an appropriate 
length of time to achieve maximum germination, (approaching 100%), and 
allow adequate but not excessive hyphal development. F or dermatophytes 
this was 20 h and for A. fumigatus 16 h incubation (Fig. 3 (a) - (d) )
Fungicidal study T. mentagrophytes var, interdigitale (DO 9941 C) was 
exposed to drug activity in liquid medium.
Actively growing hyphal cells were obtained by inoculating microconidia 
from a 10 day old culture grown on glucose peptone agar into glucose peptone
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broth to give a final concentration of approximately 8. 0 x 10 microconidia/ml. 
The broth cultures were incubated at 28^0 for 18 h. It was necessary to adjust 
the numbers of spores to achieve the optimum size of inoculum. If too many 
spores were present then germination of a significant proportion of the spores 
was inhibited. However sufficient concentration of spores was required so 
that at a la ter stage, after exposure to the drug, it was possible to dilute to 
below a fungistatic level and still maintain a suitable concentration of spores.
Freshly harvested spores from 10 day old cultures were considered to 
be the stationary phase of filamentous fungi. Suspensions containing the same 
numbers of spores as used in the preparation of actively growing hyphae were 
prepared immediately before the tests were begun,
t e s t s  f o r  f u n g is t a t ic  ACTIVnY
Agar dilution technique Stock solutions of drugs were appropriately diluted 
in distilled water and used in the preparation of Petri dishes of glucose peptone 
agar containing drug concentrations ranging from 0 . 1 -  lOOjug/ml. The agar
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FIGURE 3 Germinated spores at stage of development used in 
fungistatic investigations, (a) A. fumigatus (b) T. mentagrophytes. 
(c) M. canis and (d) T. rubrum x 150
plates were prepared In advance and stored at +4°C for 1 week to allow the 
surface to dry.
Broth dilution technique Broth dilution tests were made by inoculating the 
fungi into glucose peptone broth containing the same range of drug concentrations 
as above.
(i) Yeasts
Volumes of 0.01 ml of suspensions containing approximately 10  ^ yeast 
cells/m l w ere placed on the surface of the solid media or into broths containing 
the drugs. The Petri dishes and tubes were incubated at 28°C for 3 days and 
minimum inhibitory concentrations recorded.
Quantitative estimation of inhibition of growth
The broth dilution procedure was used to obtain a quantitative estimation 
of inhibition of growth of yeasts by taking optical density readings after 18 h 
incubation at 37^C using a CE 343 Single Sample Spectrophotometer set at a 
wavelength of 440 nm,
(ii) Filamentous fungi
Cellophane squares supporting germinated spores at optimum stage of 
development (P2l ) were removed from the agar medium, blotted to remove 
excess water (the germinated spores remained attached to the cellophane) , 
and placed fungus-side downwards onto solid media containing the selected 
drugs.
Prelim inary investigations showed that the drugs diffused freely through 
the cellophane and M. I. C, results were the same whether the squares were 
placed fungus-side-down or fungus-side-up. Placing the squares fungus-side- 
down allowed easier direct microscopy of the fungi in situ, the cellophane square
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acting as a cover slip.
In the parallel study of ungerminated spores, freshly harvested spores 
were placed directly onto the surface of the drug-containing medium.
The Petri dishes were incubated at 28°C. Observations were made 
after 1, 2, 3, 6 and 10 days and minimum inhibitory concentrations recorded.
TESTS FOR FUNGICIDAL ACTIVITY
(i) Yeasts
Tests were carried  out on actively growing and stationary phase yeast 
cells. The cell suspensions were prepared as described on p 20. Viable 
counts were made immediately before addition of the drug. These were 
adjusted to take into account the dilution factor caused by the subsequent 
addition of the drug.
Addition of 0. 5 ml amounts of 1, OOOjitg/ml concentrations of the drugs 
to 4. 5 ml amounts of the prepared cell suspensions gave final concentrations 
of lOOjLtg/ml.
The tubes were incubated at 28°C.
Sampling
(a) Comparison of the fungicidal effect of 3 imidazoles on C. albicans 
For the actively growing cells 0.1 ml samples were withdrawn at
hourly intervals up to 3 h, and for stationary phase cells at daily intervals 
up to 14 days.
(b) Comparison of the effect of econazole on four different Candida species 
Samples of 0.1 ml were withdrawn from the actively growing cell
suspensions at 10 min intervals up to 1 h, and after 3, 5, 7 and 9 h intervals, 
and from the stationary phase cell cultures at 1, 2, 3, 6 and 7 days.
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All tubes were returned to the 28^C incubator immediately after 
sampling.
-2 -3The samples were diluted to 10 and 10 and 0. 2 ml spread on the 
surface of glucose peptone agar in Petri dishes. This procedure ensured 
dilution of the drugs to below fungistatic levels.
The Petri dishes were incubated at 28°C for 3 days.
(ii) Filamentous fungi
Tests were carried  out on actively growing hyphae andfreshly harvested 
microconidia of T. mentagrophytes var. interdigitale (DO 9941 C). The 
preparation of the suspensions of the different growth phases is  described on 
p 21.
A volume of 0. 5 ml of 1, OOOjug/ml concentrations of each drug was 
added to 4. 5 ml of the spore suspensions in glucose peptone broth to give 
final concentrations of 100|Lig/ml.
Samples of 0.1 ml were withdrawn immediately before and approximately 
1 min after addition of drug and after 1, 2, 3, 5 and 7 h and after 1, 2, 4, 7 
and 16 days incubation at 28^0,
The samples were diluted 1 : 100 in sterile  distilled water and 0.2 ml 
spread on the surface of drug-free glucose peptone agar.
The Petri dishes were incubated at 28*^ C for 1 week.
MORPHOLCXÎICAL CHANGES
All fungi were examined in situ on solid medium under x 100 magnification 
and a photographic record made of the changes in cell morphology,
N. B. The inferior quality of the photographs of yeast cells (Figs, 8 -  12) 
suggests a deficiency in the method employed for their examination.
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However, although it was not possible to photograph the cells at a higher 
magnification because of the thickness of the medium, the changes in 
morphology were nevertheless clearly evident on direct microscopic 
examination.
(i) Yeasts
A comparison was made of the changes in cell morphology of actively 
growing and stationary phase cells of C. albicans exposed to lOOjug/ml 
miconazole, econazole and ketoconazole at 28^C after 3 h and 24 h.
Non-chlamydospore-forming yeasts in contact with lOOjug/ml 
econazole were examined microscopically after 24 h.
(ii) Filamentous fungi
Changes in the morphology of actively growing hyphae of filamentous 
fungi were recorded after 48 h at 28°C in sub-fungi static concentrations, 
concentrations approaching the M. I. C, and concentrations g reater than the 
M. I. C., of the 4 imidazoles examined. A comparison was made of the 
morphological effects caused by tolnaftate and griseofulvin.
PRODUCTION OF CHLAMYDOSPORES BY C. ALBICANS
Chlamydospores production was induced in C. albicans by preparing a 
cut-streak of the yeast in Czapek-Dox/Tween 80 agar. The Petri dish was 
incubated for 24 h at 28^C before examining the cells under the x 100 
magnification through the base of the Petri dish.
INVESTIGATION OF "NORMAL'" AND "UNUSUAL" YEASTS
In collaboration with Mr. E. Forbes of the Genetics Department, 
Glasgow University, an attempt was made to find a reason for the difference 
in behaviour, when exposed to sub-fungi static concentrations of the
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imidazoles, between C. guilliermondii and C. tropicalis ("unusual" yeasts) 
and C. albicans and C. parapsilosis ("normal" yeasts).
(i) An auxanographic technique (Pontecorvo et a l . ,  1953) was used to 
detect differences in nutritional requirements. The minimal medium used 
in the test was Czapek-Dox medium plus 1% glucose and 1.2% agar, pH 6, 5, 
The growth factors examined were ammonium, biotin, thiamin and pyridoxine.
(ii) Econazole nitrate was tested for the presence of contaminating growth 
factors. This was done using mutants of A. nidulans which had requirements 
for thiamin (an B8), biotin (bi - 1), proline (pro Al), pyridoxine (pyro -  4) and 
riboflavin (ribo Al). Spores of the mutants were prepared as a "lawn" in 
minimal medium and several crystals of econazole nitrate were placed in the 
centre of each Petri dish.
(iii) To investigate the possibility that the "unusual" yeasts were degrading 
the econazole to utilizable metabolites, or alternatively being stimulated by 
the presence of the drug to produce antagonistic substances which might 
interfere with low concentrations of the drug, C. guilliermondiii was grown
in lOjitg/ml econazole in glucose peptone broth for 40 h at 37°C. The medium 
was then sterilized by seitz-filtration and the filtrate diluted 1 ; 10 in fresh 
glucose peptone broth to Ijug/ml econazole, thereby ensuring an adequate 
supply of nutrients before re-inoculation with C. guilliermondii. Control 
tubes of glucose peptone broth with Ijug/ml econazole were inoculated with 
C. guilliermondii at the same time and incubated at 37^C for 2 days.
(iv) A range of growth factors was examined for ability to relieve the 
toxicity of econazole, C. guilliermondii was seeded into molten minimal 
medium agar supplemented with biotin and ammonium and containing 7. 5/ixg/ml
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econazole, poured into Petri dishes and allowed to set.
The following amino acids were tested by placing approximately 1 mg 
of the crystals onto the surface of the agar:- alanine, proline, arginine, 
methionine, phenylalanine, histidine, glutamic acid, ornithine, aspartic 
acid, threonine, cystine, glycine, valine, serine, tryptophan, tyrosine, 
cysteine, homoserine, hydroxyproline and isoleucine, together with the 
crude mixture of amino acids contained in peptone and casein hydrolysate.
The vitamins thiamin, biotin, riboflavin, nicotinamide and 
pyridoxine were tested by placing approximately 1/xg of each on the surface 
of the seeded agar.
The Petri dishes were incubated at 37^C for 24 h.
( V )  Several of the growth factors found to relieve the toxicity of econazole 
for C. guilliermondii were tested for their effect on the two "normal" and two 
"unusual" yeasts in liquid minimal medium plus ammonium and biotin containing 
20|ug/ml econazole. Approximately 20jag/ml of serine, histidine and thiamin 
were added to appropriate tubes. The same concentration of growth factors 
were added to control cultures without econazole. All tubes were incubated 
at 28^C for 5 days.
SUB-CULTURE OF C. GUILLIERMONDII AND C. TROPICALIS FROM SUB- 
FUNGISTATIC LEVELS OF THE IMIDAZOLES
(a) Econazole
Cells of C. guilliermondii and C. tropicalis were removed from the 
surface of the agar medium containing 0. 5, 1, 5, 10 and 15jug/ml econazole, 
and from a control plate, after 3 days incubation at 28°C. Suspensions of 
approximately equal turbidity were prepared in distilled water. A volume of
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0, 01 ml of each suspension was placed directly onto the surface of a series 
of the same concentrations of econazole in glucose peptone agar, and onto 
drug-free medium. The dishes were incubated at 28^C for 3 days.
After passage on drug-free medium the cells were again harvested, 
suspended in distilled water and placed on medium containing a series of 
concentrations of econazole.
An attempt was made to standardise the inocula by preparing suspensions 
of approximately the same turbidity as before.
(b) Miconazole and ketoconazole
The same procedure was followed for C. guilliermondii growing on sub- 
fungistatic concentrations of miconazole and ketoconazole.
RESISTANCE TO THE IMIDAZOLES
(i) Variation in sensitivity within a population
The Petri dishes used for the determination of M, I, C. by agar dilution 
were examined microscopically for the presence of cells capable of slow 
growth on concentrations of the drugs which completely inhibited growth of 
the rem ainder of the population.
(ii) Effect of repeated sub-culture
The least sensitive members of a population of T. mentagrophytes var. 
interdigitale which were capable of slow growth on glucose peptone agar 
containing lOjiig/ml ketoconazole were repeatedly sub-cultured at two-week 
intervals onto fresh drug-containing medium in order to select for further 
adaptation.
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(iii) Artificial induction of resistant mutants
Mr. Forbes of the Genetics Department, Glasgow University, kindly 
agreed to collaborate in trying to artificially induce resistance in 
A. nidulans with ultra-violet light as the mutagenic agent. Conidia of a 
biotin-requiring mutant of A. nidulans (bi -  1) were kept in suspension by 
constant agitation while they were irradiated for 13 min with a germicidal 
wavelength of ultra-violet light (254 nm) from a distance of 45 cm. It is 
known that approximately 5% of conidia survive this treatm ent, and of these 
approximately 1% are  mutants.
(a) Isolation of mutants
Selection for resistant mutants was carried out by plating the treated 
conidia on Czapek-Dox medium supplemented with amino acids and vitamins 
and containing a sub-fungistatic concentration of econazole.
Colonies which grew m ore rapidly than controls were sub-cultured 
onto sub-fungistatic concentrations of miconazole, econazole and ketoconazole 
in the same medium as before.
(b) Test for relief of toxicity
Conidia of the ECO -  1 mutant were inoculated into molten Czapek-Dox 
agar supplemented with amino acids and vitamins containing a fungistatic 
concentration of miconazole. Several amino acids were tested  for their 
ability to relieve toxicity by placing approximately 1 mg of the purified 
compounds on the surface of the solidified medium.
(c) Uptake of 1 -  phenylalanine
Since 1 - phenylalanine gave a wide zone of relieve of toxicity of
miconazole, uptake of this amino acid by the ECO -  1 mutant was investigated 
14with C l -  phenylalanine. The procedure was the same as that described
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14by Hackette et al. , (1970) in their study of uptake of C méthylammonium 
Ion,
(d) Comparison of M. I. C. for biotin -  requiring and ECO - 1 mutants 
of A. nidulans
The mutants were passaged on drug-free glucose peptone agar before 
determining the M. I. C. of miconazole, econazole and ketoconazole by 
the broth dilution test.
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R E S U L T S
FUNGISTATIC ACTIVITY
(i) Yeasts
Minimum Inhibitory Concentrations
The M. I, C. s of the imidazoles for different Candida species are 
listed in Table I, Active and stationary phase cells were inhibited by the 
same concentration of each imidazole. Direct microscopic examination of 
the inocula placed on solid media revealed a degree of initial cell multiplication 
after both growth phases were exposed to fungistatic concentrations of the 
imidazoles. Identical results were obtained using broth and agar dilution 
tests.
An anomalous feature, firs t observed in tes ts  on solid media 
containing econazole, was the behaviour of two of the yeasts, C. guilUermondii 
and C. tropicalis. They showed a marked inhibition of growth at 0.5 and 
l^g/m l. Growth then increased again at 5 and lOjug/ml before decreasing at 
15jug/ml to give an M. I. C. of 20jLig/ml.
The other species, C. parapsilosis. C. pseudotropicalis and 
C. albicans behaved as expected, i .e .  the amount of growth steadily decreased 
with increase in concentration of the drug until the M. I. C. was reached.
C. guilliermondii responded in a sim ilar manner to increasing 
concentrations of miconazole and ketoconazole, although in keeping with 
lower sensitivity of the fungus to ketoconazole the peak of partial recovery 
was less apparent and appeared at higher concentrations (50 -  lOOjug/ml).
Quantitative estimation of inhibition of growth
The optical density readings were a m easure of the amount of light 
travelling through the cell suspensions and were therefore inversely
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ORGANISM
MiLiïiJjtSZSi)
Econazole Miconazole Ketoconazole
C. albicans (BP 3496B) 15 15 50
C. parapsilosis (BP 34181 10 N. T. 50
C. pseudotropicalis (BP 33441 5 N.T. N.T.
C. tropicalis (BP 34371 20 N. T. > 100
C, guilliermondii (BP 34391 20 20 > 100
N, T. = not tested
t a b l e  I M. I. C. OF IMIDAZOLES FOR CANDIDA SPECIES
proportional to the amount of growth. A graph (Fig. 4) was prepared from 
the reciprocals of the O.D. readings.
(ii) Filamentous fungi
Minimum Inhibitory Concentrations are listed in Table II.
As already observed for yeasts, microscopic examination of the 
inocula revealed that growth continued for a short time after the cells came 
into contact with fungistatic concentrations of the imidazoles.
D irect microscopic examination of hyphae had a distinct advantage 
over conventional techniques in that it allowed accurate readings of M. I. C, 
levels to be made in a shorter time. This was particularly evident with the 
slower growing dermatophytes. It was found that results recorded after 3 days 
were unchanged after 7 - 1 0  days.
The M. I. C. results obtained for actively growing hyphae and for 
spores were identical except for A. fumigatus exposed to miconazole and 
econazole. Slightly lower concentrations of these two imidazoles were 
required to inhibit germination of A. fumigatus spores than were required 
to inhibit growth of the hyphae.
The drug which was most effective against dermatophytes was 
tolnaftate, (0.1 -  0. 5|ug/ml), however its activity against A. fumigatus 
was negligible. The imidazoles showed a wider spectrum of activity than 
both tolnaftate and griseofulvin, and of these, econazole was the most 
effective (1 - Sjug/ml). Miconazole and clotrimazole followed closely behind 
econazole (5 -  l^ g /m l) , but ketoconazole gave consistently higher M. I. C. s 
(up to 50|ng/ml) indicating a correspondingly lower level of in vitro activity 
although its spectrum of activity was sim ilar to the other imidazoles.
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Iti general, the dermatophytes appeared to be m ore sensitive than 
A. fumigatus to the antifungal agents tested.
FUNGICIDAL ACTIVITY 
(i) Yeasts
(a) Comparison of the effect of 3 imidazoles on C. albicans
Fig. 5 illustrates the rate  of killing of C. albicans cells following
exposure to lOO/Ltg/ml of the drugs.
With econazole and miconazole the actively growing cells were 
rapidly killed by the drugs within 1 h. Stationary phase cells were 
apparently unaffected up to 24 h, but by 3 days a fungicidal effect was 
evident. Killing was complete in 9 days with econazole, while miconazole 
required slightly lo i te r  (12 days).
For ketoconazole, lOOjug/ml was not totally fungicidal for either 
actively growing or stationary phase cells of C. albicans within 14 days.
(b) The effect of econazole on four different Candida species
The fungicidal effect of econazole on active and stationary phase cells 
of four Candida species is illustrated in graph form in Fig. 6,
C. guilliermondii and C. tropicalis were more sensitive than C. albicans 
and C. parapsilosis to the fungicidal action of econazole in both the actively 
growing and stationary phases.
In all cases viability of actively growing cells dropped rapidly within 
the f irs t 10 rain after addition of the drug. Killing was complete within 
40 min for C. guilliermondii and C. tropicalis, and within 3 h for C. albicans 
and C. parapsilosis.
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The viability of stationary phase cells of all 4 species remained 
unaltered after 1 h at 28^C, however after 3 h the viability of C. guilliermondii 
began to diminish and killing was complete for both C. guilliermondii and 
C. tropicalis in 24 -  48 h. Viability of C, parapsilosis was significantly 
reduced within the firs t 24 h but some cells of this non-chlamydospore -  
forming species were still viable after 3 days.
The behaviour of C. albicans conformed to that of the previous experiment, 
stationary phase cells remained fully viable up to 24 h in the presence of lOOjug/ml 
econazole, after which the viability gradually diminished until total killing was 
achieved by 7 days.
(ii) Filamentous fungi
The decrease in viability of active and stationary growth phases of 
T. mentagrophytes exposed to lOOjug/ml of the imidazoles is  shown in Fig. 7.
As with the yeasts, the fungicidal activity of miconazole and econazole 
was greatly influenced by the growth phase of the fungi.
Actively growing hyphae showed a dramatic drop in viability immediately 
after addition of the drugs and killing was complete within 3 -  5 h.
Spores were very much m ore resistant to the fungicidal activity of 
these drugs, viability only gradually diminishing over a period of 1 week.
Ketoconazole differs from the other imidazoles in failing to kill actively 
growing hyphae within the 3 - 5 h observed for miconazole and econazole. 
However, it was considerably more effective than the other two drugs in its 
action against ungerminated spores. Only a very small proportion of viable 
cells remained after 2 days, and total killing of both actively growing hyphae 
and spores was achieved within 4 days.
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MORPHOLOGICAL CHANGES
(i) Yeasts
Actively growing cells of C. albicans which had been in contact with 
econazole and miconazole for 3 h produced a few buds before being killed.
A proportion of these buds were more elongate than normal cells but no 
other changes were noted (Fig. 8 a & b).
The actively growing cells in contact with ketoconazole multiplied a 
greater number of tim es to produce short chains of spherical cells (Fig. 8 c).
No further multiplication took place between 3 and 24 h, but morphological 
changes were apparent. On all 3 drugs the cells appeared to shrink.
(Fig. 9 a, b & c).
Stationary phase cells of C. albicans recommenced multiplication on 
all 3 drugs during the f irs t 3 h of contact although this development was less 
on econazole than on the other 2 imidazoles. In all cases the cells appeared 
morphologically normal at a magnification of x 400 (Fig. 10 a, b & c).
However, the inoculum of stationary phase cells continued to multiply after 
the 3 h period and in addition there were changes in their morphology. By 
24 h they had increased in size and become refractile ("chlamydospore-like”) 
(Fig. 11 a, b & c).
Non-chlamydospore-forming yeasts also continued to multiply for 
several hours after exposure to fungistatic concentrations of the imidazoles 
but, in contrast to C. albicans, they retained their normal appearance when 
exposed to lOOjug/ml econazole for 24 h. Stationary phase cells neither 
became enlarged In size nor refractile in appearance (Fig, 12 a). Actively 
growing cells did not shrink (Fig. 12 b).
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FIGURE 8 Appearance of actively growing cells of C. albicans after
3 h in contact with (a) econazole (b) miconazole and (c) ketoconazole x 150
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FIGURE 9 Appearance of actively growing cells of C. albicans after
24 h in contact with (a) econazole (b) miconazole and (c) ketoconazole
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FIGURE 10 Appearance of stationary phase cells of C. albicans after
3 h in contact with (a) econazole (b) miconazole and (c) ketoconazole
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FIGURE 11 Appearance of stationary phase cells of C. albicans after
24 h contact with (a) econazole (b) miconazole and (c) ketoconazole
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FIGURE 12 Appearance of the non-chlamydospore-forming yeast, 
C. parapsilosis. after 24 h in contact with lOO^g/ml econazole:
(a) stationary phase cells (b) actively growing cells x 150
(ii) Filamentous fungi
(a) Morphological effects of the imidazoles
The following description summarizes the general trend in the 
behaviour of the filamentous fungi on sub-fungi static concentrations, 
concentrations approaching the M. I. C. and concentrations greater than the 
M. I. C. (The M. I. C, for each drug against the various fungi are listed in 
Table II).
The normal appearance of hyphae growing for 24 h on glucose peptone 
o
agar at 28 C is shown in Fig. 13 (a) -  (d).
When exposed to low concentrations of the imidazoles the fungal 
hyphae were stunted, but no modification in morphology occurred (Figs. 14
(a), 16(a), 17 (a) ).
On concentrations approaching the M. I. C ,, thickened refractile cells 
developed, and A. fumigatus and M. canis also produced rounded 
chlamydospores. The hyphae continued to grow slowly until colonies became 
easily visible in 7 - 10 days (Figs. 14 (b), 15 (a), 16 (b ), 17 (b) ),
On minimum inhibitory concentrations and above limited initial growth 
allowed the development in the dermatophytes of thickened refractile areas 
along the length of the hyphae, but as the time of exposure and/or the 
concentration of the drugs increased these areas diminished in size and 
became replaced by "empty" shrunken cells which were found to be non- 
viable (Figs. 14 (c), 15 (b), 16 (c), 17 (c) ).
(b) Morphological effects of tolnaftate and griseofulvin
Tolnaftate and griseofulvin also caused the production of swollen and 
refractile areas along the hyphae (Figs. 18 (a) & (b), 19 (a) ).
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On low concentrations of griseofulvin "curling" of the hyphae was 
apparent (Fig. 19 (b) ). This "curling" effect is peculiar to griseofulvin 
and was not caused by any of the other antifungals tested. Comparable 
concentrations, (i, e. lower than the M. I. C, ), of the imidazoles and 
tolnaftate m erely caused stunting of growth.
CHLAMYDOSPORE PRODUCTION BY C. ALBICANS
The term inal chlamydospores produced by C. albicans after 24 h 
at 28^C on Czapek-Dox/Tween 80 medium are shown in Fig. 20.
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FIGURE 13 Normal hyphal development after 24 h on d rug-free glucose
peptone agar (a) A. fumigatus (b) T. mentagrophytes (c) M. canis
and (d) T. rubrum  x 150
FIGURE 14 The development of germinated spores of A. fumigatus during 
48 h at 28°C in (a) A sub-fungistatic concentration of miconazole (5)Lig/ml)
(b) A concentration of miconazole approaching the M. I. C. (lO^g/ml) and
(c) A concentration of miconazole greater than the M. I. C. (50|:ig/ml) x 150
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FIGURE 15 The development of germinated spores of T. mentagrophytes 
var. interdigitale during 48 h at 28 C in (a) A concentration of econazole 
approaching the M. I. C. (0. 5^g/ml)* and (b) A fungistatic concentration of 
econazole (1/xg/ml) x 150
* lowest concentration photographed
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FIGURE 16 The development of germinated spores of M. canis during 
48 h at 28°C in (a) A sub-fungistatic concentration of ketoconazole 
(lOjLtg/ml) (b) A concentration of ketoconazole approaching the M. I. C. 
(20^g/ml) and (c) A fungistatic concentration of ketoconazole (50^g/ml) 
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FIGURE 17 The development of germinated spores of T. rubrum during 48 h 
at 28°C in (a) A sub-fungistatic concentration of clotrimazole (0. 5^zg/ml)
(b) A concentration of econazole approaching the M. 1. C. (1/xg/ml)* and
(c) A fungistatic concentration of clotrimazole (5^g/ml) x 150
* The equivalent clotrimazole plate was unreliable due to "dumping" of 
precipitated drug.
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FIGURE 18 Morphological effects caused by 0. l/xg/ml tolnaftate after 
48 h (a) T. mentagrophytes var. interdigitale (b) T. rubrum x 150
tFIGURE 19 Morphological effects of griseofulvin on T. mentagrophytes 
var inter digitale after 48 h (a) A fungistatic concentration (lO^g/^1) and
(b) ’’Curling” on a sub-fungistatic concentration (0 .1/ig/ml) x 150
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FIGURE 20 Terminal chlamydospores of C. albicans. Formed after 
24 h at 28®C on Czapec-Dox/Tween 80 medium x 150
DIFFERENCES BETWEEN ’NORMAL^ AjND ^UNUSUAL' YEASTS
(i) The auxanographic tes t used to detect differences in nutritional 
requirements showed that C. albicans and C. parapsilosis were stimulated 
to a greater extent by biotin and thiamin than were C. guilliermondii and 
C. tropicalis.
(ii) No contamination of the econazole nitrate with biotin or thiamin was 
detected,
(iii) Culture filtrates of the cells growing in the presence of sub-fungistatic 
concentrations of econazole failed to stimulate the growth of freshly 
inoculated yeasts,
(iv) Several amino acids, (histidine, serine, aspartic acid, cystein, glycine 
and homo serine), plus peptone and casein hydrolysate and the vitamins 
biotin and thiamin were found to stimulate the growth of the yeasts in the 
presence of sub-fungi static levels of econazole.
(v) Only thiamin showed an ability to preferentially relieve the toxicity of 
econazole for the two "unusual” yeasts. C, albicans and C, parapsilosis were 
not affected by the addition of 2QLig/ml thiamin to minimal medium supplemented 
with ammonia and biotin, whereas C, tropicalis and C, guilliermondii were 
inhibited by addition of the same concentration of this vitamin to the medium.
In medium containing 20jug/ml econazole, thiamin relieved the toxicity of 
econazole for C, guilliermondii and C, tropicalis but not for C, albicans and 
C. parapsilosis.
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SUB-CULTURE OF C. GUILLIERMQNDn AM) C. TROPICALIS FROM SUB- 
FUNGISTATIC LEVELS OF THE IMIDAZOLES
(a) Econazole
Sub-cultures of C. guilliermondii and C. tropicalis, taken from the 
Petri dishes used to determine the M. I. C, (p22) after 3 days, showed different 
sensitivities depending on whether they were inoculated directly onto fresh 
medium containing econazole, or whether they were f irs t  passaged on drug- 
free medium.
Both species behaved in the same manner.
Table HE compares the results obtained with C. guilliermondii 
following sub-culture directly (Fig, 22 a), and after passage on drug-free 
medium (Fig. 22 b), onto medium containing a range of concentrations of 
econazole.
Fig, 21 illustrates in histogram form the resu lts obtained by sub- 
culturing directly and after passage onto equivalent concentrations.
Cells taken from 0, 5 and I f i g / m l  concentrations appeared better adapted, 
after passage on drug-free medium, to growth at these concentrations than 
previously unexposed cultures, although the M, I, C, remained unaffected,
(b) Miconazole and ketoconazole
As with econazole a second exposure to miconazole and ketoconazole led 
to increased sensitivity of C. guilliermondii when made directly, and to 
decreased sensitivity when transferred  via a drug-free medium.
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TABLE III RESPONSE OF C. GUILLIERMONDII TO ECONAZOLE 
FOLLOWING DIRECT SUB-CULTURE FROM MEDIUM 
CONTAINING THE DRUG. AND AFTER PASSAGE ON 
DRUG FREE MEDIUM
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Diagrams to illustrate position of various inocula and concentrations 
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FIGURE 22 Growth of C. guilliermondii sub-cultured from sub- 
fungistatic concentrations of econazole (control, 0. 5, 1, 5, 10 and 15jig/ml).
(a) Transferred directly onto medium containing the same concentrations as 
before (b) Transferred via drug-free medium in which grown for 3 days at 
28°C (See previous page for key to illustrations. )
RESISTANCE TO THE IMIDAZOLES
(i) Variation in sensitivity within a population
Within a population of fungal cells o r spores a small number seem 
able to grow slowly on concentrations which completely inhibit the res t of 
the population. Fig, 23 (a) shows the development of a micro-colony of 
C. albicans after 6 days on lOOjitg/ml ketoconazole. Fig, 23 (b) illustrates 
a sim ilar result with the filamentous fungus T. rubrum after 6 days on 
iSjLtg/ml ketoconazole.
(ii) Effect of repeated sub-culture
Repeated sub-culture of T, mentagrophytes var, interdigitale on sub- 
fungistatic concentrations of ketoconazole failed to detect any further 
adaptation of the least sensitive members of the population.
(iii) Artificially induced resistance in A, nidulans
(a) Isolation of mutants
The U. V. irradiated conidia of A. nidulans (bi -  1) yielded seven 
mutant colonies which grew more rapidly than controls on medium containing 
a sub-fungistatic concentration of econazole. Sub-culture of these mutants 
onto sub-fungistatic concentrations of miconazole, econazole and ketoconazole 
showed that all 7 isolates possessed a degree of resistance to all 3 imidazoles.
One of these mutants was chosen for further study. It was larger and 
lighter in colour than the other resistant colonies and was designated ECO -  1,
(b) Relief of toxicity
It was found that fo r the re sis tan t mutant 1 -phenylalanine gave a wide
zone of re lie f of toxicity from  fungistatic levels of miconazole.
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(c) uptake of l.-phenylalanine
Using I-phenylalanine it was shown that uptake of this amino acid 
was reduced by a half in the resistant mutant compared to the parent strain 
(Fig. 24).
(d) Comparison of M. I. C. s for biotin -  requiring and ECO - 1 mutants
of A. nidulans
ECO -  1 was consistently more resistant to the effect of the imidazoles. 
The resistance to the three imidazoles varied -  compared with the original 
biotin requiring mutant, the ECO -  1 mutant was twice as resistant to 
miconazole, 7 tim es more resistan t to econazole and 4 tim es more 
resistant to ketoconazole (Table IV).
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FIGURE 23 R esistant colonies developing afte r 6 days on ketoconazole
(a) C. albicans on lOOng/ml (b) T. rubrum on IS^g/ml x 150
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FIGURE 24 1-Phenylalanine uptake by cells of biotin-requirlng parent and
econazole-resistant mutant of A, nidulans
MUTANT M. I, C.
MICONAZOLE
ECONAZOLE
KETOCONAZOLE
b i - 1  
ECO - 1 
bi — 1 
ECO - 1 
b i - 1  
ECO -  1
7. 5 jLtg/ml 
15 
1
7.5
1
4
TABLE IV COMPARISON OF M. I. C. s FOR BIOTIN- 
REQUmiNG AND ECO - 1 MUTANTS OF 
A. NIDULANS
DISCUSSION
The procedures used for these investigations gave reproducible results 
which were broadly in agreement with those of other workers.
Provided inocula were of a standard size, measurements of fungistatic 
activity were the same whether made in liquid or solid media, and only for 
A. fumigatus was there a different drug response between active and stationary 
phases. Conidial germination of A. fumigatus was, perhaps surprisingly, 
inhibited by slightly lower concentrations of miconazole and econazole than 
was required to inhibit growth of the hyphae (Table II), The cellophane 
square technique has the advantage of allowing estimation of fungistatic 
activity much sooner than by conventional broth dilution tests.
In in vitro tests the established drugs tolnaftate and griseofulvin 
compared favourably with the imidazoles in their activity against dermatophytes. 
However, the spectrum of antifungal activity of these drugs is limited -  they 
are not active against A. fumigatus or yeasts.
The imidazoles have a much broader spectrum of activity. All the 
organisms tested were sensitive to a g reater or le sse r extent to all four 
azole derivatives examined. Econazole was the most active of these compounds, 
closely followed by miconazole and clotrimazole. Ketoconazole gave 
consistently higher M. I. C. levels which at f irs t sight might indicate that it 
is a less useful compound. However, as the in vivo activity of antifungals 
is greatly influenced by the reaction of the host and the ability of the antifungal 
to reach the site of infection, it is inadvisable to predict the in vivo efficacy 
of these drugs solely from in vitro results.
Direct microscopic examination of the inocula exposed to fungistatic 
concentrations of the imidazoles revealed a degree of initial cell 
multiplication for both active and stationary phase yeast cells, and for
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actively growing hyphae of filamentous fungi. Whether or not metabolic 
changes occurred in spores of mycelial fungi is not known, but their 
morphology remained unaltered and the increase in size usually observed in 
spores prior to germination was not noted. Since these investigations were 
made, this feature of a short growth period before inhibition has been 
described by other workers (Plempel, 1979 and Haller, 1979). A sim ilar 
delay in growth inhibition for several generations is  well documented for 
the antibacterial drug sulphonamide (Davis et a l . , 1968). Throughout this 
study the definition of M. I. C. was taken to mean "that concentration of drug 
required to inhibit continued growth".
The fact that growth continues for a short time after exposure to the 
imidazoles, and morphological changes occur in response to the adverse 
conditions created by the drugs, suggests that the cells may possess a store 
of enzym es/substrates/products/energy reserves, which protects them from 
an immediate effect of the drugs.
The nature of the mechanisms involved is unclear. A proportion of 
the new cells formed by C. albicans in the presence of miconazole and 
econazole were malformed, and short chains of cells were produced by this 
yeast exposed to ketoconazole. Under normal conditions C. albicans buds in 
a random fashion to produce rounded clumps of spherical or short oval cells. 
The abnormal growth may be the result of direct interference with the 
formation of the new cell wall, e. g, by interfering with ergosterol synthesis 
as suggested by Van den Bossche, (1978), but it could also be a consequence 
of disruption of one or more of the many other metabolic processes involved 
in survival and growth of the cell.
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The fungicidal action of 10(^g/ml miconazole and econazole against 
actively growing C. albicans was rapid, the m ajority of cells were killed 
within 1 hour. Similar results have been obtained by other workers such 
as Iwata et a l . , (1973 a) who reported that 20 -  spjug/ml clotrimazole caused 
almost total loss of viability of C. albicans within 2 hours, and Swamy et al. , 
(1974) who found a total cidal effect within 4 hours when cells of C. albicans 
were exposed to lO/ng/ml miconazole.
Stationary phase cells of C. albicans were, however, markedly more 
resistant to the fungicidal effect of the imidazoles and the question arose as 
to whether the ability of this yeast to form chlamydospores was influencing 
the results of tests.
C hlamy do spore formation is a characteristic feature which is used in 
the laboratory to separate C. albicans from other Candida species.
The term inal chlamydospores (Fig. 20) produced by C. albicans in 
Czapek-Dox/Tween 80 and certain other media, are not morphologically 
indentical to the "chlamydospore-like" cells observed in this study.
Nevertheless it is possible that the same mechanism may be involved and 
the response of C. albicans to the drugs may therefore be different from 
those yeasts which do not naturally form chlamydospores.
Examination of the fungicidal effect of econazole on 3 non-chlamydospore -  
forming Candida species showed that actively growing cells of C. guilliermondii 
and C. tropicalis were markedly more sensitive to the drug than were 
C. albicans and C. parapsilosis. This sensitivity was even more strikingly 
exhibited when stationary phase C. guilliermondii and C. tropicalis were 
exposed to the drug and, to a lesser extent, also by C. parapsilosis. The
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viability of stationary phase C. parapsilosis began to diminish within 24 h, 
while that of C. albicans declined more slowly, total killing not being 
achieved until after 7 days.
No "chlamydospore-like" structures were produced in response to the 
drug by the 3 non-chlamydospore - forming yeasts, so it is probable that the 
ability of C. albicans to form these structures contributes to the survival of 
this species. However, the wide variation in results between different non- 
chlamydospore -  forming species indicates that chlamydospore formation 
is not the only factor influencing sensitivity to fungicidal activity and the 
"unusual" behaviour of C. guilliermondii and C. tropicalis f irs t observed 
on sub-fungistatic concentrations of the imidazoles in agar medium may be 
relevant. This behaviour, also quantified by optical density measurements 
in broth culture, m anifests itself as a low, broad peak or "hump" in the 
graph of growth versus concentration of drug (Fig. 4). The phenomenon has 
not been previously described for the imidazoles, nor does there appear to 
be any reports of a sim ilar response with other antifungal o r antibacterial 
agents.
Tests to try  to establish the reason for the differences between "normal" 
and "unusual" yeasts suggest that thiamin may be involved since this 
vitamin preferentially relieves the toxicity of econazole for C. guilliermondii 
and C. tropicalis but not for C. albicans and C. parapsilosis.
Thiamin contains a thiazole group which is sim ilar to the imidazole 
group of econazole and it is possible that the two compounds may compete 
for the same uptake site or enzyme system within the cell (Fig, 25).
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FIGURE 25 Structural formulae of thiamin and econazole nitrate
Growth of a strain  of A. aidulang., with a requirement for thiamin 
( an B8) indicated that the glucose peptone medium contained in the region of 
]/xg/mI thi azole, (the breakdown product of thiamin after sterilization),
(Mr. E, Forbes, personal communication ), and one explanation, therefore, 
for the behaviour of C. guilliermondii and C. tropicalis in the presence of 
low levels of inidazole drugs is of antagonism between the two molecules.
Since thiamin at 20|pig/ml inhibited growth of C. guilliermondii and 
C. tropicalis another explanation is  that the effect of low concentrations 
of the imidazoles on these fungi is cumulative to thiamin in the medium,
(by interfering with the same mechanism), and causes the significant reduction 
in growth observed at low levels of the imidazoles. At higher levels of the 
drugs an alternative pathway may be stimulated which overcomes the block 
in the main pathway and there is an increase in growth to give the pealc of 
partial recovery. This may also account for the higher M. I. C, s of the 
imidazoles for these two yeasts when compared with C. albicans and 
C. parapsilosis (Table I). At still higher levels, ( the M. I. C. and above), 
both pathways are blocked and growth ceases.
This explanation may also be applied to the behaviour of 
C. guilliermondii exposed to low concentrations of imidazoles and then 
transferred  directly to fresh medium containing the drugs. The cumulative 
effect of double exposure results in an increased sensitivity to low levels of 
the drug. However, if the fungi are firs t passaged on drug-free medium, 
this cumulative effect is  lost although the alternative pathway remains 
stimulated and the capacity of the cells to grow on equivalent low 
concentrations is  enhanced.
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The study of the morphological changes in sensitive fungi caused by 
the antifungal drugs suggests that since "resistant" structures are 
produced by filamentous fungi in response to concentrations just below the 
M. I. C, of all the drugs examined, that these are non-specific changes 
and simply a reaction by the fungi to adverse environmental conditions, 
and not a manifestation of interference with any particular metabolic activity. 
However, all four imidazoles cause sim ilar changes in morphology on 
equivalent concentrations, (stunting on low concentrations; development of 
"resistant" structures at the M. I. C. ; and shrinkage on higher concentrations), 
and it might be expected that they have a sim ilar mode of action.
The shrinkage of actively growing hyphae exposed to concentrations of 
the imidazoles greater than the M. I, C. indicated that killing was probably 
being achieved and this was confirmed by tests for fungicidal activity. These 
tests clearly showed that the imidazoles are as effective against filamentous 
fungi as against the yeasts and that the activity of miconazole and econazole 
is much greater against actively growing hyphae than against stationary 
phase spores.
The rapidity with which reduction in viability of the actively growing 
hyphae took place suggests that the drugs are either being taken up extremely 
rapidly by these cells or are binding to some component of the hyphal cell 
wall o r membrane which is not present, or possibly only present in very 
small amounts, in the spores,
Ketoconazole differs from the other imidazoles. It fails to kill actively 
growing cells of either yeasts or mycelial fungi as rapidly as miconazole and 
econazole and its fungicidal activity against stationary phase yeasts is also 
correspondingly lower. However, it is considerably more effective than the
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other two drugs against ungerminated spores of T. mentagrophytes, (the 
time required to achieve killing was approximately half that required for 
miconazole and econazole).
This ability of ketoconazole to exert a relatively efficient fungicidal 
effect on ungerminated spores may be related to its water solubility which 
might be expected to allow easier penetration of the drug through the spore 
wall. Whatever the reason, this fungicidal activity is a property which may 
compensate for the lower fungistatic activity of ketoconazole compared to 
other imidazoles.
Although some variation in sensitivity to the imidazoles exists within 
a population of fungal cells, repeated sub-culture on drug-containing medium 
of the least sensitive m embers of a population of T. mentagrophytes failed to 
induce further adaptation.
The increased ability to grow on sub-fungistatic concentrations of the 
imidazoles observed with C. guilliermondii after drug exposure and passage 
on drug-free medium was not accompanied by a corresponding increase in 
M, I, C, and does not represent an increase in resistance. However, the 
production of resistant mutants of A. nidulans by means of a mutagenic agent 
indicates that modifications to the genetic m aterial of this fungus can confer 
a degree of resistance to the imidazoles, and the mechanism therefore 
exists for resistance to arise  spontaneously.
Since there was a reduced ability of the resistant mutant to take up 
phenylalanine the possibility exists that resistance may result from a sim ilar 
reduction In uptake of the imidazole molecule, but other explanations, such as 
an enhanced ability to detoxify the drug once it has entered the cell, are also 
possible.
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EXPERIMENTAL SECTION 2
IN VIVO ACTIVITY OF ANTIFUNGALS
I N T R O D U C T I O N
It is not possible confidently to extrapolate from in vitro sensitivity 
m easurements to use of these drugs in therapy of fungal infections in man.
The only reliable m easure of therapeutic efficacy comes from clinical tria ls .
Fungi are  able to a lter their morphology according to environmental 
conditions. They may form structures which are more resistant and have a 
lower metabolic activity than the normal vegetative form. Within the tissues 
of a host such structures may be formed and will be more resistant to 
antifungal agents than the actively growing phase. When therapy is 
discontinued, these resistant forms will be capable of developing to initiate 
further infection.
The accessibility of the fungus to the drug is also of great importance. 
With dermatophytes, the fungal elements are protected by their growth deep 
in the keratin and for an antifungal agent to be effective, sufficiently high 
levels must be achieved at the site of fungal activity.
Numerous reports on the efficacy of topical application of the imidazoles 
are described in the literature and reviewed by Sawyer et al. , (1975 a, b) and 
Raab (1977). Although they indicate a high activity of clotrimazole, miconazole 
and econazole, treatm ent failures are not uncommon (Gentles, Jones & Roberts, 
1975).
Topical therapy has many limitations and systemic treatm ent via the 
oral route is  the method of choice. However, this form of therapy is 
influenced by a number of factors such as toxicity and side-effects of the 
therapeutic agents, absorption from the gastro-intestinal trac t, and 
induction of host enzymes which may degrade the active molecule.
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The value of animal experiments is limited by species -  dependent 
differences between the experimental animal and man. When griseofulvin 
was firs t investigated for use in treatm ent of ringworm, clinical tria ls  
showed it to be of little  value when applied topically (Williams et a l . , 1959). 
Later, when the drug had been shown to act by the systemic route, Frey & 
Geleick (1960) reported that griseofulvin was effective when applied 
topically to experimental guinea pig trichophytosis. Clearly, the animal 
model had severe deficiencies in this particular instance. However, animal 
experiments can be of value by providing a useful step between in vitro 
studies and clinical tr ia ls  in man. Griseofulvin was f irs t shown to be 
effective by the oral route in treatm ent of ringworm in guinea pigs 
(Gentles, 1958) and found equally effective by the same route in man 
(Williams et a l . , 1959).
Griseofulvin was the f irs t antifungal to be discovered which fulfilled 
the c rite ria  laid down by Wilson in 1955: "The ideal antifungal drug even 
for the superficial mycoses would seem to be one which could be safely 
administered internally in amounts sufficient to endow the cells eventually 
destined to produce keratin with power to res is t fungi completely, this 
power persisting as they become keratinized, and the drug thus exerting 
its effect from within outward”.
During recent years several other antifungals, including a number of 
imidazoles, have been investigated for their activity via the oral route 
against experimental guinea pig dermatophytosis.
Clotrimazole and Janssen 34,000 were found to be ineffective,
(Gentles & Jones, unpublished data). The induction in the host of an enzyme 
capable of inactivating clotrimazole is  now accepted as the reason for the
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failure of this drug (Shadomy, 1970).
A new imidazole, tioconazole, supplied by Pfizer Limited was also 
tested in this laboratory (Gentles & Ball, unpublished data) and found not 
to be active by the oral route even though it achieved higher serum levels 
than did miconazole which is poorly absorbed from the gastro-intestinal 
tract.
One compound, Bayer 4364 was found to modify the course of infection 
sufficiently to be considered effective in curing established guinea pig 
ringworm (Gentles & Jones, unpublished data) but was la te r reported to 
cause exfoliative derm atitis.
The water soluble imidazole, ketoconazole, produces relatively high 
drug levels in body fluids after oral administration to man and animals 
(Janssen Pharmaceutica, 1978). An experiment was designed to test the 
in vivo activity of ketoconazole when administered orally to ringworm infected 
guinea pigs. The results reported here have been accepted for publication in 
a joint paper describing the in vitro and in vivo activity of this new imidazole 
(Odds, M ine, Gentles & Ball, 1980).
The guinea pig model of dermatophytosis was also used to compare the 
efficacy of topically applied miconazole with tolnaftate, already established as 
a useful drug for topical treatm ent of ringworm.
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M A T E R I A L S  AND M E T H O D S
MATERIALS
FUNGI
T. mentagrophytes var, mentagrophytes and M. canls originally 
obtained from clinical m aterial and preserved on silica gel (Gentles & Scott, 
1979) were used to prepare inocula from 10 day old cultures on glucose 
peptone agar.
EXPERIMENTAL INFECTION OF ANIMALS
The hair was clipped and shaved from the shoulder area  of guinea pigs 
weighing between 350 g and 400 g and the eiythematous site was inoculated 
with the test fungi.
F or the study of the therapeutic efficacy of ketoconazole 10 guinea pigs 
were infected with T. mentagrophytes and 10 with M, canis, and for the 
comparison of topically applied miconazole and tolnaftate 6 guinea pigs were 
infected with T. mentagrophytes.
DRUGS
Ketoconazole for oral administration was incorporated in a pellet of 
ground-up diet bound together with flour and water.
Two per cent miconazole was supplied by Janssen Pharmaceutical Ltd. , 
as a cream (Ddctarin) for topical application. The placebo preparation 
(control) was the vehicle for the drug,
Tolnaftate was supplied by Glaxo Laboratories as a 1% cream 
(Tinaderm).
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METHODS
THERAPEUTIC REGIMEN
Orally administered ketoconazole. Five of each batch of animals were 
treated with a daily dose of 40 -  50 mg/kg ketoconazole administered orally. 
Control animals were left untreated. With T. mentagrophytes -  infected 
animals, treatm ent was started 3 days after infection, by which time fungal 
invasion of keratin is  known to be established (Fig. 26). For animals infected 
with M. canis. treatm ent was started 8 days after infection, when the lesions 
were fluorescent under a Wood’s light. Treated and control animals were 
sacrificed at intervals and m aterial from the infected sites was examined 
histologically. The animals were examined each day and observations were 
recorded.
Topically applied miconazole and tolnaftate. Treatm ent was commenced 
3 days after infection when invasion of tissue by T. mentagrophytes was 
established. (E arlier treatm ent may indicate only the result of in vitro 
activity against the fungal inoculum. ) The preparations were applied twice 
daily, (a.m . and p.m . ). One guinea pig from each drug treatm ent, 
(miconazole and tolnaftate) and a control animal (placebo), was sacrificed 
after 3 days and the rem ainder after 5 days treatm ent and sections of skin 
were prepared for histological examination. The stain used to demonstrate 
the presence of fungal elements in the tissue was periodic acid-Schiff (P. A. S. ).
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PERIODIC ACID-SCHIFF STAIN
1. Bring sections to water.
2. Oxidize for 10 min in 1% aqueous periodic acid.
3. Wash in running water for 5 min and rinse in
distilled water,
4. Place in Schiff’s reagent for 10 - 20 min.
5. Rinse three times in 1% aqueous sodium
metabisulphite, freshly prepared,and 
wash in running water for 10 min.
6. Counter stain in haematoxylin.
7. Wash and blue in Scott's tap water substitute
(0.35% sodium bicarbonate, 2% magnesium 
sulphate),
8. Dehydrate, c lear and mount.
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R E S U L T S
THERAPEUTIC EFFICACY OF ORAL KETOCONAZOLE IN 
EXPERIMENTAL GUINEA PIG DERMATOPHYTOSIS
In guinea pigs infected with T. mentagrophytes, a marked clinical 
improvement of the lesions was noted by comparison with controls after 
3 days' oral administration of ketoconazole. Histological examination 
showed that there was almost complete eradication of fungi from infected 
sites after 6 days' treatm ent (Table V),
The earliest signs of resolution of infection were apparent in the 
lowest regions of the hair follicles, and eventually, in treated animals, 
only the distal portion of the hairs remained affected (Fig. 28) while 
in the equivalent control animals almost all hair follicles were heavily 
invaded (Fig, 27),
In M. canis- infected animals, treated from the eighth day after 
infection, sim ilar histological changes occurred (Table V), Clinically 
there was a reduction in the inflammatory response and in the extent of 
hair loss from the infected area (Fig. 29 a, left) by comparison with the 
untreated animals in which inflammation eventually caused complete hair 
loss at the site of infection (Fig. 29 a, right). In animals infected with 
T. mentagrophytes, treated with ketoconazole from the third day of 
infection, the inflammatory response was barely detectable and the m ajor 
clinical features were scaling and erythema; in untreated animals the 
lesions became highly inflammatory (Fig, 29 b) and ran a natural course of 
22 - 25 days when they resolved with total loss of hair at the site of infection.
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Animal infected with
No. of 
Treatments
Histological Examination  ^
Treated Untreated
T. mentagrophytes
+ + 4 4 - +
4 4 - + +
+ 4 4 - +
2
M. canis ++
+
++++
+ 4 4 - +
++++
1. Treatment commenced 3 days after infection
2. Treatm ent commenced 8 days after infection
3. Scores ranged from + = a few follicles infected distally to
+ 4 4 - +  = a m ajority of hair follicles infected at all levels
TABLE V THERAPEUTIC EFFICACY OF KETOCONAZOLE
IN DERMATOPHYTE INFECTIONS IN GUINEA PIGS
FIGURE 26 Section of guinea pig skin 3 days after infection with 
T. mentagrophytes. Fungal hyphae (arrows) in base of homy layer and 
in upper parts of hair follicles. P. A. S. stain x 80
I
FIGURE 27 Section of guinea pig skin 7 days after infection with 
T. mentagrophytes. Almost all hair follicles are deeply invaded (arrow). 
P. A. S. stain x 80
FIGURE 28 Section of guinea pig skin 7 days after infection with 
T. mentagrophytes and 4 daily treatm ents with ketoconazole, 40 -  50 mg/kg. 
A few fungal hyphae are present only at distal end of hair (arrow). P. A. S. 
stain X 80
FIGURE 29 Experimental guinea pig dermatophytosis (a) Comparison of 
treated (left) and control (right) following successful therapy (b) Inflammatory 
response in untreated animal 14 days after infection
c o m p a r is o n  o f t h e  e f f ic a c y  of t o p ic a l l y  a p p l ie d
MICONAZOLE AND TOLNAFTATE
Both antifungals showed a beneficial effect by reducing the inflammatory 
response and minimizing hair loss at the inoculation site. There was no 
significant difference clinically between the animals treated with miconazole 
and tolnaftate. Histologically, after 3 days treatm ent, both antifungals 
produced a marked reduction in the amount of fungus present compared with 
controls. After 5 days treatm ent the amount of fungus was further reduced 
although neither treatm ent had succeeded in completely removing all traces 
of the invading fungus.
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D ISC U SSIO N
The results of oral treatm ent of guinea pig dermatophytosis with 
ketoconazole clearly demonstrate the potential of this new imidazole in the 
treatm ent of dermatophyte Infections in man.
The rapidity of the therapeutic effect reflects the results of investigations 
which have shown rapid absorption and distribution of ketoconazole in 
experimental animals and humans, (Janssen Pharmaceutica, 1978),
There is every indication that ketoconazole behaves in vivo in a sim ilar 
manner to griseofulvin. Invasion of new keratin is apparently inhibited and 
the rate of clearance of infection is  dependant on the rate  of keratin production. 
The broad spectrum of in vitro antifungal activity and the demonstration 
of the efficacy of this drug in the treatm ent of rabbits infected experimentally 
with C. albicans (Odds et a l . ,  1980) adds further support to the view that 
it may prove to be a promising new drug for the treatm ent of both superficial 
and systemic mycoses.
In the comparison of topically applied miconazole and tolnaftate no 
significant differences were detected in the efficacy of the two drugs under 
the conditions of this experiment. There was no doubt of the beneficial 
effect of treatm ent but, the deficiencies (see p 50 ) of the guinea pig as an 
animal model for estimation of topically applied drugs must be taken into 
account.
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G E N E R A L  D ISC U SSIO N
Imidazole drugs have made considerable impact upon the therapy of 
fungal infections as is evident from the number introduced for clinical use 
within recent years. They all have a broad spectrum of activity, but each 
has its own individual characteristics. Some of these are  beneficial, others 
detrimental, e .g . clotrimazole is  absorbed from the gastro-intestinal trac t, 
but is subsequently degraded by liver enzymes; miconazole and econazole 
are  not absorbed in sufficient quantity to give active blood levels and for 
systemic use must therefore be administered intravenously. Ketoconazole 
is readily absorbed when given orally, and serum levels remain relatively 
constant throughout the treatm ent period. Although side effects are  known 
to occur with some of the imidazoles, they are not as serious as with certain 
other systemically administered antifungals such as the polyene antibiotics.
The antifungal potency of imidazoles as determined by M. I. C. 
measurements also differs, although many of the variations reported can be 
accepted only when comparable tests have been made under standard 
conditions. This is exemplified by the considerable variations in M. I. C. 
values which are to be found in the literature and can only be attributed to 
differences in procedures used by the various investigators. In this study 
the use of a standard procedure allowed direct comparisons to be made.
If measurements of fungistatic activity require to be carefully evaluated 
before acceptance, the reports of fungicidal activity require even more 
critical scrutiny. The reasons for this are clear from some of the problems 
encountered during this study and apply to other drugs as well as imidazole 
derivatives. Surprisingly, some investigators have omitted to take into 
account the effect of "carry - over" of drug from the exposure medium to
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the viability tes t medium. This is a basic problem with all water insoluble 
drugs and not only, as shown here, with imidazoles. It is this factor that 
probably accounts for the report by Weinstein et a l . , (1964) that tolnaftate is  
fungicidal for T. mentagrophytes. The procedure described by these workers 
is likely to have allowed carry  -  over of fungistatic drug levels and in addition 
it is possible that the drug solvent levels used may have affected their results. 
In 1978, K essler et a l . , using a technique sim ilar to the procedure adopted 
in this study, could find no fungicidal effect for tolnaftate against 
T. mentagrophytes. K essler's results may be considered m ore reliable than 
those of Weinstein. However, the duration of the experiment may have been 
too short to m easure fungicidal activity and sampling over a longer period 
may have revealed that tolnaftate is also fungicidal. There is clearly a 
need for establishment of c rite ria , e .g . drug concentration and exposure tim e, 
for defining fungicidal activity.
Yet another factor of importance is the physiological state of the fungus 
which may be related to age and morphological form of the culture. The 
concentration of the population exposed to the drug must also be considered. 
Yamaguchi & Iwata (1979) emphasised the importance of making measurements 
of fungicidal activity on sim ilar cell populations at the same cellular 
concentrations. They report that with increased drug concentrations 
miconazole exhibits a distinct fungicidal action but that the effects of 
clotrimazole remain fungistatic. However, the resu lts of this study, while 
clearly demonstrating the fungicidal activity of miconazole, also indicate 
by the morphological changes induced by clotrimazole that this imidazole is 
fungicidal.
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The demonstration of differences in activity of the imidazoles for 
active and stationary growth phases is  not surprising, and has previously 
been recorded by other workers. The differences are not, however, as 
extreme as has been suggested by Plempel (1976) for clotrimazole who 
stated that no sporicidal effect could be expected because its mode of 
action required active metabolism of the cells. Van den Bossche, (1974) 
and Van den Bossche et a l . , (1975) describe a marked fungicidal activity of 
miconazole for actively metabolising cells of C. albicans and not for 
resting cells. From the results of this study it can be concluded that the 
imidazoles investigated, (miconazole, econazole and ketoconazole), are 
fungicidal for both actively metabolising and stationaiy phase cells, although 
the times required to achieve killing may vary considerably.
It should be noted that ketoconazole, which has a lower fungicidal 
activity than miconazole and econazole for actively growing cells of both 
T. mentagrophytes and C. albicans, was much more effective at killing 
stationary phase cells of T. mentagrophytes. This property gives further 
support to the accumulating evidence that ketoconazole may prove to be a 
significant advance on other imidazoles.
As far as the mode of action of the imidazoles is concerned, firm  
conclusions are  not yet possible and the results of in vitro studies suggest a 
multiplicity of effects.
The findings of Yamaguchi, (1977, 1978) and Kuroda et a l . , (1978), 
that unsaturated fatty acids and phospholipids antagonize the activity of the 
imidazoles, and the observation by Van den Bossche, (1974) that labelled 
miconazole becomes localized in the cell walls and plasmalemma of
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actively growing cells suggests that the imidazoles are  binding to some lipid 
component of the cell wall or membrane. Binding to lipids probably also 
explains the antagonistic effect of cremophor observed in this study. Such 
an hypothesis is  further supported by the very rapid effect of miconazole 
and econazole on actively growing hyphae of T. mentagrophytes.
The consequences of this binding may be either to directly interfere 
with the integrity of the cell membrane to allow leakage of cell components 
and therefore indirectly disrupt the metabolic processes within the cell, 
or to block uptake sites for essential metabolites required for biosynthetic 
processes.
The marked differences in behaviour of active and stationary phase 
cells to the fungicidal activity of the imidazoles may reflect differences 
in the rate  of uptake of the drug. Either the lower rate of metabolic activity 
or the decreased permeability of the cell wall of stationary phase cells may 
be responsible for reducing drug activity. Alternatively stationary phase 
cells may possess a store of enzymes which can detoxify the drug, or cell 
metabolites produced in response to the drug such as the raised hydrogen 
peroxide levels demonstrated by De Nollin et a l . , (1977).
Van den Bossche (1974) reported that miconazole did not affect 
amino acid uptake by C. albicans. However, Yamaguchi & Iwata (1979), 
working with the same fungus, found that both miconazole and clotrimazole 
at minimum inhibitory concentrations inhibited uptake of leucine. The 
findings, during these investigations, of competition for uptake sites in 
C. guilliermondii between thiamin and econazole, and in the resistant 
mutant of A. nidulans for phenylalanine are in agreement with those of
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Yamaguchi & Iwata, i. e. that inhibition of amino acid uptake is one effect 
of imidazoles on sensitive fungi.
Competition for uptake sites may also explain the remarkable 
phenomenon of partial recovery shown by certain yeasts in the presence 
of the imidazoles. Experiments showed that thiamin provided relief of 
imidazole toxicity for these yeasts. However, the requirement for thiamin 
by many fungi is well known, (Hawker, 1950), and a m ore complex mechanism 
of drug action may eventually be discovered. Whatever the explanation, a 
practical problem of the phenomenon would arise  in the use of these yeasts 
for investigations such as serum level estimations.
The behaviour pattern of fungi on repeated exposure to imidazoles must 
also be considered when attempting to explain their mode of action.
Increased sensitivity results when fungi are sub-cultured directly from 
drug-containing to drug-containing medium indicating a cumulative effect of 
the drugs possibly as a result of binding to the lipids in the cell membrane. 
This cumulative effect can be overcome by allowing the fungi to develop on 
drug-free medium for a short period of time and the M. I. C. returns to 
normal. However, the previous exposure to sub-fungistatic concentrations 
of the drugs allows the fungi to become better adapted to growth on these 
same concentrations. One explanation of this behaviour is that low levels of 
the imidazoles stimulate an alternative metabolic pathway to overcome 
blocking of the main pathway. This alternative pathway rem ains active at 
sub-fungistatic concentrations but minimum inhibitory concentrations are 
capable of blockirg both pathways. Exactly which pathways are involved 
is unknown, although ergo sterol biosynthesis, catalase and peroxidase
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activity and oxidative phosphorylation have all been suggested as possible 
target sites for the imidazoles, (Van den Bossche et a l . , 1978, De Nollin 
et al. , 1975, 1977 and Dickinson, 1977).
The changes in fungal morphology brought about by the imidazoles are 
not unique. Tolnaftate and griseofulvin also cause swollen and refractile 
areas in hyphae of susceptible mycelial fungi. This common reaction of 
fungi to adverse environmental conditions created by drugs, highlights the 
adaptability of fungal cells to overcome changes in their environment and 
emphasises the problems that may be encountered in the treatm ent of 
infections. In this respect the ability of stationary phase cells of C. albicans 
to produce "chlamydospore-like" structures in response to fungistatic 
concentrations of the imidazoles must be taken into account in any attempt 
to extrapolate the results obtained using this species to other sensitive fungi. 
The production of chlamydospore-like cells by C. albicans in the 
presence of drugs has previously been described in the literature. Lee 
(1973) reports "chlamydospore-like" cells induced by 5-fluorocytosine and 
the formation of "enlarged bubble-shaped cells" produced by C. albicans 
in the presence of lOjitg/ml econazole has been described by P reusser (1976). 
Photomicrographic studies by P reusser revealed that these cells contained 
great quantities of lipid bearing substances.
Despite a knowledge of the ability of C. albicans to form "resistant" 
chlamydospores much of the published work on imidazole activity, (Iwata 
et al. , 1973 a, b; De Nollin & Borgers, 1974; Van den Bossche, 1974 and 
Swamy et al. , 1974), has been done solely with this species.
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The comparative study of fungicidal activity of econazole against 
C. albicans and non-chlamydospore-forming yeasts indicates that chlamydospore 
production may be one factor accounting for the ability of stationary phase 
C. albicans cells to re s is t fungicidal action for a tim e. However, the 
considerable variation in the time required to kill stationary phase cells of 
different non-chlamydospore-forming yeasts points to the involvement of other 
factors. For example, the extreme sensitivity of C, guilliermondii and 
C, tropicalis may be connected with the "unusual" behaviour of these yeasts 
on sub-fungi static concentrations of the imidazoles.
Development of drug resistance has presented considerable problems 
in the treatm ent of bacterial infections but so far has not proved to be 
particularly troublesome in the treatm ent of the mycoses. Nevertheless, 
different species of fungi vary in their sensitivity to antifungals, and in 
addition certain isolates of susceptible species which are naturally more 
resistant are occasionally encountered. Such resistance is , however, 
generally of a low order such as 2 -  5 tim es greater than in normal strains 
and hardly comparable with the increased drug resistance developed by some 
bacteria. A notable exception is 5-fluorocytosine, and problems of 
resistance arising during the course of treatm ent with this drug are  well 
documented, (Shadomy, 1969). There is a single report by Holt & Azmi 
(1978) of the emergence of resistance to miconazole of C. albicans during 
prolonged therapy, but this has not so far presented a problem in practice.
Variation in sensitivity to the imidazoles within a population of fungal 
cells as observed in this study has recently been discussed by Plempel (1979),
He reports the "slow regrowth of initially inhibited colonies" in agar
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diffusion and agar dilution tests with imidazole antimycotics when the 
incubation time is prolonged. This effect is usually explained as being the 
result of selection of variants resistant to the drugs. However, as far as 
the imidazoles are  concerned this is contradicted by the fact that the fungi 
do not have increased M. I. C. values when the test is repeated.
Selection of the least sensitive members of the population of C. albicans 
during therapy would have been an obvious explanation for the rise  in M, I. C. 
levels of the isolate described by Holt & Azmi (1978) but there is  no support 
for this from in vitro investigations.
However, the demonstration of 2 -  to 7 -  fold resistance of an 
artificially induced mutant of A, nidulans indicates that a mechanism exists 
for resistance to develop naturally. Whether this will prove to be the case in 
treatm ent of fungal infections, can only be assessed after long-term usage 
of the drugs.
The in vitro inhibitory effect on dermatophytes of the antifungals 
tolnaftate, miconazole and econazole are sim ilar, and so any differences in 
efficacy of these agents in topical treatm ent of fu ira i infections will depend 
on their ability to penetrate so that an adequate concentration of the drug 
reaches the infecting fungus.
In vivo studies using guinea pigs experimentally infected with ringworm 
provide valuable information concerning the clinical potential of these drugs. 
However, experimental infection with T. mentagrophytes in guinea pigs 
runs a much more rapid course than dermatophyte infection in man. 
Inoculation of guinea pigs Involves scarification of the skin which renders 
the stratum corneum more permeable to topically applied agents. The
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subsequent development of a heavy fungal infection in the host also contributes 
to the breakdown of the keratin b a rrie r and aids penetration by the antifungal 
agent. Treatment tria ls  must be made within the short period between 
establishment of infection and onset of an inflammatory response i, e, 
between approximately 3 days and 8 days, during which time the horny 
layer is disrupted and permeable.
In man, treatm ent of fungal infection does not generally take place until 
some time after infection, and although the horny layer in the central area 
of the lesion may be disrupted and allow penetration of topically applied 
agents, the surrounding area will still be intact although hyphal development 
may have extended into the lower layers of the epidermis. It has been shown 
that fungus is present up to 6 cms away from the marginal zone of lesions, 
(Knudsen, 1975).
The results of the comparison of tolnaftate and miconazole indicate that 
both are equally effective in curing experimental guinea pig dermatophytosis, 
and despite the deficiencies of the guinea pig model these results are consistent 
with the findings of various clinical tria ls , reviewed by Clayton (1979), that no 
significant differences have been found between these agents in the treatm ent of 
dermatophyte infections in man. However, a mycological cure rate of only 
60% was achieved with miconazole in topical treatm ent of tinea pedis in 
sportsmen (Gentles et al. , 1975), as compared with the 100% success obtained 
in this study using guinea pigs.
The guinea pig is a more reliable model for testing orally administered 
drugs since it is the route of transport and the effect of the antifungal at the 
site of fungal infection which is being examined. The physical state of the 
stratum corneum and the extent of the lesion is of no consequence. This has
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proved to be the case for griseofulvin and there is no reason to believe that 
it will not be also for ketoconazole.
The findings that orally administered ketoconazole is effective against 
ringworm infections in guinea pigs and Candida infections in rabbits 
(Odds et a l . , 1980) therefore represents a considerable step forward in 
antifungal therapy by combining broad spectrum antifungal activity with 
acceptable pharmaco-kinetic properties.
There can be little doubt that the imidazole group of antifungals, 
while not without certain disadvantages, appear to possess many of the 
properties desirable for use in the treatm ent of mycotic infections in man 
and the synthesis of new imidazole derivatives is continuing at various 
centres. It is hoped that these investigations may be successful in finding 
other compounds with even greater activity and lower toxicity which will 
further advance the therapy of the mycoses.
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